简介：
Overview
This study presents two non-invasive methods for chronic control of neuronal activity using chemogenetics in mice. It focuses on less invasive delivery techniques for clozapine-N-oxide (CNO), utilizing eye drops and drinking water to minimize animal stress while allowing for sustained neuronal activation.
Key Study Components
Area of Science
- Neuroscience
- Chemogenetics
- Animal Behavior
Background
- Remote control of neuronal activity is crucial for various experimental paradigms.
- DREADDs (Designer Receptors Exclusively Activated by Designer Drugs) are commonly used for this purpose.
- Traditional methods can involve significant stress and intervention for the animals, which this study aims to address.
Purpose of Study
- To provide alternatives for chronic CNO administration in mice.
- To minimize stress in animals during neuronal activation protocols.
- To validate the effectiveness of the new delivery methods.
Methods Used
- The study uses a mouse model for chemogenetic manipulation.
- Delivery of CNO was done either via repetitively applying eye drops or administering it through drinking water.
- Protocols were developed for both approaches, including acclimatization phases for animals.
- Detailed surgical and administration procedures were described to ensure repeatability.
Main Results
- Repetitive CNO delivery through eye drops significantly induced cFos expression in infected neurons.
- The effectiveness of CNO persisted during repetitive exposures.
- Daily water consumption was not adversely affected by the CNO addition, indicating a successful method of administration without negative impacts on hydration.
Conclusions
- This study demonstrates effective, non-invasive methods for chronic neuronal control, facilitating cleaner experimental design.
- These protocols can be adapted to various experimental settings with minimal animal stress.
- Insights gained can enhance understanding of neuronal mechanisms and their control.
What are the main advantages of the new CNO delivery methods?
The new methods are non-invasive and minimize animal stress. They also enable chronic control of neuronal activity over extended periods.
How is the CNO administered via eye drops?
CNO is delivered as a stable droplet close to the cornea without touching the eye, ensuring accurate dosage while minimizing stress.
What is the significance of the study's findings?
The findings validate that chronic neuronal activation can be achieved with minimal intervention, allowing for studies that require sustained neuronal control.
Can these protocols be adapted for various experimental designs?
Yes, the protocols can be tailored to accommodate different DREADD variants and experimental setups, enhancing their versatility.
What types of data are obtained from these methods?
The methods yield data related to neuronal activity, including molecular readouts such as cFos expression in response to CNO delivery.
What key considerations must be taken when implementing these methods?
Researchers should acclimate animals properly to handling and ensure accurate dosing of CNO based on body weight to optimize results.
繁體中文
